[1]
2014. Evidence for the Conversion of Docetaxel into 7-Epidocetaxel in Patients Receiving Conventional Taxotere® Based Chemotherapy. Journal of Analytical Oncology. 3, 2 (Apr. 2014),  73–78. DOI:https://doi.org/10.6000/1927-7229.2014.03.02.1.